THE OBJECTIVE OF THIS CONTRACT IS TO USE IMMUNOGENS (ENVS) COMBINED WITH EFFECTIVE MULTIVALENT ANTIGENIC DISPLAY ON NANOPARTICLES (NPS) FOR DELIVERY TO PROMOTE STRONG AND LONG-LIVED NEUTRALIZING ANTIBODY RESPONSES AGAINST HIV AND DIRECT AFFINITY MATURATION TOWARD HIV NEUTRALIZING ANTIBODIES.

DEFINITIVE CONTRACT won by ANTAGEN BIOSCIENCES INC · work in BOSTON, MA
$599,914
RecipientANTAGEN BIOSCIENCES INC UEI HXD6EFH2ND57
Award ID75N93019C00014
Award amount$599,914
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSCAN12
Set-asideSmall business
Start dateJun 17, 2019
End dateApr 30, 2022
Place of performanceBOSTON, MA
Record updatedDec 1, 2021

View the official award record

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids